This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lorus Therapeutics Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Howard Cukier: Innovator in Cancer Treatment
Introduction
Howard Cukier is a notable inventor based in Stoney Creek, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective solutions for various types of cancer.
Latest Patents
Cukier holds a patent for "2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer." This invention provides compounds that are capable of inhibiting the proliferation of several types of cancer cells, including renal, pancreatic, prostate, colon, leukemia, brain tumors, and non-small cell lung cancer. His patent represents a promising advancement in cancer therapy.
Career Highlights
Howard Cukier is associated with Lorus Therapeutics Inc., a company dedicated to developing innovative cancer therapies. His work at Lorus Therapeutics has been instrumental in advancing the understanding and treatment of cancer through novel compounds.
Collaborations
Cukier has collaborated with notable colleagues, including Yoon S Lee and Venkata Nedunuri. These partnerships have contributed to the success of his research and the development of effective cancer treatments.
Conclusion
Howard Cukier's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to inspire advancements in the field of oncology.